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Introduction
Localized amyloidosis, also referred to as amyloidoma, is a
rare type of amyloidosis in which the amyloid deposition is
focal. In soft tissues, various localizations including the
breasts, the respiratory and gastrointestinal tract, and the
central nervous system have been reported.1–11 In contrast,
solitary amyloidoma of the bone is rare. In the axial skeleton,
the thoracic spine is most commonly involved, followed by
the cervical spine.12–24 However, the involvement of the
sacrum is extremely rare; only two cases have been reported
previously.25,26
Amyloidoma of the bone is a benign tumorlike lesion
characterized by bone destruction and extension into the
adjacent soft tissue. At the level of the axial skeleton, the
destruction of the bonemay result in vertebral instability and
compression of the spinal cord.12,15,18,19
The clinical and radiologic diagnosis of amyloidoma may
be difﬁcult due to its variable clinical manifestations and
unspeciﬁc radiologic ﬁndings on plain ﬁlms, computed to-
mography (CT) scans, and magnetic resonance imaging
(MRI).18,27–29 Deﬁnitive diagnosis is based on histopathology
including immunohistochemistry for IgG lambda and kappa
light chains and the demonstration of amyloid protein A (AA)
and anti-transthyretin in tissue obtained byan open biopsy or
ﬁne needle aspiration.7,8,11,27,29
Due to the frequent development of neurologic deﬁcits,
amyloidomas of the axial skeleton are usually treated
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Abstract Study Design Case report.
Objectives With only two previously reported cases, localized amyloidosis of the
sacrum is extremely rare. Here we report a 64-year-old woman with a large osteolytic
lesion accompanied by weakness and paresthesia of the right leg and difﬁculties in
bladder control.
Methods Fine needle biopsy and standard staging procedures revealed a primary
solitary amyloidoma that was treated with intralesional resection, lumbopelvic stabili-
zation, and consolidation radiotherapy.
Results Clinical follow-up revealed the diagnosis of multiple myeloma 9 months after
initial treatment. At 12 months, no local recurrence has occurred, the neurologic
symptoms have resolved, and the systemic disease is in remission.
Conclusions Intralesional resection with adjuvant radiotherapy of the amyloidoma
achieved good local tumor control with limited morbidity.
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surgically. The clinical course of the local lesions is usually
favorable. However, the overall prognosis depends on the
presence or development of a systemic disease. Those cases
are usually associated with a poor prognosis.30 Here we
report the rare case of a localized amyloidoma of the sacrum,
its diagnosis, and its surgical and oncological treatment as
well as the later clinical course.
Case Report
A 64-year-old woman with a history of several years of lower
back pain presented to our clinics with increasing pain and
neurologic deﬁcits including weakness and paresthesia of the
right leg and difﬁculties in bladder control. Conventional radio-
graphs and a CT scan revealed a large osteolytic tumor
(75  60  55 mm) with destruction of the posterolateral
aspect of the sacrum extending the right sacroiliac joint. MRI
of the sacrum showed an extradural mass with low signal
intensity onT1-weighted and enhanced intensity onT2-weight-
ed images with complete obliteration of the spinal canal below
S1 (►Fig. 1). Single-photon emission CT and intravenous con-
trast CTof the thoraxand the abdomendidnot showany further
skeletal lesions or signs for a primary tumor or metastases.
A CT-guided needle biopsy was performed. Upon histo-
logic analysis, the tumor consisted of amyloid deposits as
revealed by typical apple-green birefringence following
Congo red staining. Amyloid deposits were partially en-
gulfed by multinucleated giant cells, and an accompanying
lymphocytic inﬁltration was found. Immunohistologic
Fig. 1 Preoperative computed tomography (transversal plane) at the
level of SI joint and magnetic resonance imaging (coronal plane) scan
show the osteolytic tumor and extradural mass (75  60  55 mm)
with low signal in T1-weighted and inhomogeneous enhancing inten-
sity in T2-weighted images with complete obliteration of the spinal
canal below S1.
Fig. 2 Hematoxylin and eosin (A) and Congo red (B) staining of the
biopsy material in 100 magniﬁcation. The biopsy largely consists of
rather homogeneous, pale pink, nonﬁbrillary, amorphous extracellular
mass (amyloid, A, asterisk), which typically stains brick red in a Congo
stain (B) and reveals a classical apple-green birefringence under
polarized light. Giant cells of the foreign body type were found as a
reaction to the amyloid deposits (A, arrow).
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speciﬁcation of the amyloid deposits revealed lambda light
chain amyloidosis (AL; ►Fig. 2).
Multiple myeloma was excluded by bone marrow biopsy
and immunoelectrophoresis of the serum and the urine.
Systemic amyloidosis was ruled out by MRI of the heart
and biopsies of the colon and the kidney. The results of the
preoperative blood examination are shown in ►Table 1.
En bloc tumor resection was not possible without sacriﬁc-
ing the L5 to S3 nerve roots. Therefore, an intralesional
resection was performed by a posterior approach. The tumor
tissue was very brittle and the resection was performed in a
piecemeal fashion with curettage and suction. The L5 to S3
nerve roots were decompressed. Lumbopelvic stabilization
from L4 to the ileumwas performedwith amodiﬁedGalveston
technique using the USS Ileosacral system (DePuy Synthes,
Oberdorf, Switzerland) because the sacrum could not be used
for screw placement due to its lytic destruction.31,32 Solid
screw purchase could only be achieved in the supra-acetabular
region of the right ilium. All nerve roots aswell as the presacral
iliac vessels could be separated from the tumor mass and
Table 1 Preoperative blood examination
Parameter Value Standard value
Hemoglobin (g/L) 93 121–154
Hematocrit (L/L) 0.28 0.36–0.44
Erythrocytes (T/L) 3.33 3.90–5.00
Leukocytes (G/L) 5.10 3.50–10.5
Neutrophils 2.36 1.60–7.40
Eosinophils 0.42 0.02–0.40
Basophils 0.04 0.00–0.15
Monocytes 0.38 0.20–0.93
Lymphocytes 1.93 1.10–3.50
Thrombocytes (G/L) 212 140–380
Na (mmol/L) 142 132–142
K (mmol/L) 4.50 3.50–4.70
Ca (total, mmol/L) 2.25 2.10–2.55
Ca (ionized, mmol/L) 1.23 1.13–1.30
PO4 (mmol/L) 1.48 0.84–1.45
AST (U/L) 16.0 <35.0
ALT (U/L) 24.0 <35.0
ALP (U/L) 155 35.0–105
GGT (U/L) 325 5.00–36.0
LDH (U/L) 329 <480
PTH (pg/mL) 50.0 15.0–65.0
25-hydroxy vitamin D3 (nmol/L) 50.0 23.0–113
1,25-dihydroxy vitamin D3 (pmol/L) 32.0 48.0–160
CRP (mg/dL) 12 <5.0
Serum protein electrophoresis (%)
Albumin fraction 54.6 56.8–66.2
α-1 globulins 4.9 3.0–5.3
α-2 globulins 10.9 7.20–11.4
β globulins 11.4 8.70–12.7
Gamma globulins 18.2 11.0–18.7
β2 microglobulin (µg/mL) 6.7 <3.0
Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; GGT, gamma-glutamyl
transpeptidase; LDH, lactate dehydrogenase; PTH, parathyroid hormone.
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preserved. Sufﬁcient soft tissue coverage after tumor resection
and lumbopelvic stabilization was achieved. Primary wound
closure was performedwithout the need for soft tissue recon-
struction. The surgical intervention took 3 hours 45 minutes,
and the intraoperative blood loss was 1,700 mL. No intra-
operative or postoperative complications occurred (►Fig. 3).
Histopathologic analysis of the surgical specimen revealed
dense tumor-forming amyloid deposits and an accumulation
of mature clonal plasma cells revealing a lambda light chain
restriction and monotypic expression of IgG (►Fig. 4). Bone
marrow biopsy was repeated and again revealed no evidence
of multiple myeloma. In the demonstrated absence of sys-
temic disease, the diagnosis of a primary solitary amyloidoma
of the sacrum was made. Surgical treatment was followed by
uneventful consolidation radiation therapy (50 Gy total dose,
given in 25 fractions over 5 weeks).
At 6 months’ follow-up, the patient showed no signs of
local recurrence, had regained neurologic function of the
lower extremities completely, and had normal bladder and
bowel control. At 9 months, a restaging including serum
immunoelectrophoresis showed elevated plasma levels of
lambda light chains, which now indicated systemic disease.
Along with new radiologic ﬁndings of osteolyses of the
cranium and the proximal femur, multiple myeloma was
diagnosed and the ﬁnal diagnosis of the sacral tumor was
revised to “multiple myeloma-associated amyloidoma.” Stan-
dard induction chemotherapy with bortezomib and dexa-
methasone was initiated. At 12 months’ follow-up (►Fig. 5)
the patient was free of local disease at the sacrum and the
systemic disease was in remission. The osteosynthesis was
stable and intact, and the patient was mobile without neuro-
logic impairment.
Discussion
Amyloidoses are a heterogenous group of diseases character-
ized by the extracellular deposition of amyloid in various
locations. The disease can be localized or systemic and is
deﬁned according to the deposited protein (e.g., serum AA,
light chain amyloid, β 2-microglobulin, transthyretin).27 In
systemic forms, the precursor protein is released into the
circulation in its soluble form and deposited as amyloid in
various locations. Localized amyloidosis, also referred to as
amyloidoma, appears as a circumscribed lesion that may
occur in the breast, lung, gastrointestinal tract, central ner-
vous system, and bone.1–11,27,29,30 Amyloidomas present as
tumorlike lesions with signs of malignant tumor
growth.15,18,28,29,33 In localized amyloidosis of the bone,
the lesions are usually composed of immunoglobulin kappa
or lambda light chains (AL amyloidoma).27,29,30 The accumu-
lation of AL amyloid in the bonemay be primary or associated
with systemic disease in the context of multiple myeloma. In
Fig. 3 Intraoperative situ after intralesional tumor debulking and
spinopelvic stabilization. On the right side, resection included the
medial aspect of the ilium; therefore, two iliac screws were necessary.
The dural sac was circumferentially cleared below the spinous process
of L5 (triangle), and the exiting roots S1 and S2 (asterisks) were
decompressed.
Fig. 4 Hematoxylin and eosin staining and immunostaining for
lambda light chains (inlay upper left) of the intraoperatively retrieved
specimen in 400magniﬁcation. The biopsy largely consists of sheets
of mainly mature plasma cells as well as islands of homogenous, pale
pink, nonﬁbrillary, amorphous extracellular mass (amyloid, asterisks).
Fig. 5 Biplanar view of a computed tomography reconstruction of the
pelvis 12 months after surgery. The large defect is still visible but not
progressing, and the implant material is intact without signs of
loosening. There is a small lytic lesion visible in the right ileum
indicative for multiple myeloma (arrowheads).
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the latter case, monoclonal immunoglobulin light chains are
also present in the blood.29,34
Skeletal involvement of localized AL amyloidosis is unusual.
Most cases have been reported in the spine, preferentially in
the thoracic and cervical part.12–24 With only two reported
cases so far, affection of the sacrum as in our case is extremely
rare.25,26 Clinical presentation of amyloidoma in the axial
skeleton varies. Depending on the location, size, and involve-
ment of neural structures patientsmay be asymptomatic, have
localized back pain, or show varying degrees of neurologic
symptoms including radiculopathy, paraparesis, and paraple-
gia.14–16,26,33,35–38 Pathologic fractures are rare.15,26,38,39
Involvement of the skeleton may lead to bony destruction
mimicking other locally aggressive processes including in-
fections or malignancies such as chondrosarcoma, lympho-
ma, and bone metastases.15,18,28,29,33 On conventional
radiographs, amyloidoma of bone presents as lytic lesions
with varying degrees of calciﬁcation. Cortical disruption may
be present due to the expansion of amyloid deposits into the
surrounding soft tissue.13 For lesions at the level of the axial
skeleton, an evaluation with respect to potential instability
and neurologic affection is needed. Computed tomography is
well suited to evaluate bone destruction and instability with
well-known limitations to assess the expansion into the soft
tissue.15,36 On MRI, amyloidoma usually exhibit low to inter-
mediate signal intensity on both T1- and T2-weighted images
with variable contrast enhancement on T1-weighted im-
ages.15,40 However, MRI is not speciﬁc in the diagnosis of
localized amyloidosis.
The amyloidoma in our case presented as a lytic lesion
with a calciﬁed matrix on conventional radiographs and CT
scan. The lesion had signs of malignant tumor growth such as
the destruction of the posterolateral aspect of the sacrum
with extension over the right sacroiliac joint. Our differential
diagnoses were chondrosarcoma, lymphoma, and metastatic
disease. Such aggressive appearance has also been described
for the two reported cases of localized amyloidosis of the
sacrum.25,26 In agreement with the literature, MRI ﬁndings
in our case showed a spinal epidural mass but were other-
wise unspeciﬁc for the diagnosis of the lesion. In accordance
with Bruninx et al25 and Grifﬁn et al,26 deﬁnite diagnosis
could not be made based upon the imaging studies. There-
fore, the ﬁnal diagnosis requires the histopathologic demon-
stration of typical apple-green birefringence of the amyloid
upon staining with Congo red and an examination under
polarized light.7,27,29,30,41 Subsequently, immunohisto-
chemical characterization of the chemical type of amyloid
is required. Because localized amyloidosis of the bone are
composed of AL amyloid, immunostainings for kappa and
lambda immunoglobulin light chains to prove clonal restric-
tion should be performed.29,41 To exclude secondary or
inﬂammation-associated amyloidosis, immunohistochemi-
cal characterization should also include AA, anti-transthyr-
etin, and β 2-microglobulin.27
In the absence of neurologic symptoms, amyloidoma can
be managed conservatively by observation and serial imag-
ing. In cases with increasing pain, instability, or cord com-
pression, surgery is indicated. Usually, a decompressive
procedure with tumor excision is performed. Subsequently,
anterior and/or posterior stabilization may be required. Sur-
gery should aim at complete excision of the mass while
avoiding any neurologic deﬁcit. In large tumors with exten-
sive soft tissue expansion, complete excision may not be
possible or associated with a high risk of complications and
morbidity. Given the lack of neurologic symptoms, one of the
two so far reported cases was observed without speciﬁc
treatment.26 The other patient was treated surgically with
bilateral laminectomy from S1 to S3 and complete excision of
the tumor mass. No adjuvant therapy was performed.25 The
lesion reported by Bruninx et al was limited to the body of S2
with expansion into the left neuroforamen of S1.25At 75  60
 55 mm, the amyloidoma we present was very large
(►Fig. 1) and complete resection was not possible without
removal of the L5 to S3 nerve roots. To limit themorbidity, we
decided to perform an intralesional resection with postoper-
ative radiation therapy. The role of radiation therapy in
localized amyloidoma of the bone has not been established,
but seemed reasonable given the similar clinicopathologic
features of localized amyloidoma and plamacytoma.27,28,30,42
Other amyloid deposits or an underlying multiple myeloma
have to be ruled out with adequate procedures, as in our
patient.
Whether primary amyloidomas represent a benignplasma
cell neoplasm or a plasmocytoma with local amyloid produc-
tion is controversial. The outcome of localized amyloidoma is
determined by the presence or the development of multiple
myeloma. A localized extraosseous plasma cell clone associ-
ated with localized amyloidosis may not necessarily imply an
increased risk of progressing to systemic disease.34,43,44
Lipper and Kahn reported three patients with amyloidomas
of the bone who did not develop multiple myeloma over a
follow-up period of up to 12 years.7 In contrast, Pambuccian
et al stated that amyloidomas of the bone in fact represent
plasmacytomas with a frequent later progression to multiple
myeloma.30 Unfortunately, this has been the case in our
patient, who developed multiple myeloma 9 months after
local therapy. Therefore, the initial diagnosis of primary
solitary amyloidoma of the sacrum was revised to multiple
myeloma-associated localized amyloidoma. This case high-
lights that careful follow-up of patients with localized amy-
loidosis is mandatory to ensure initiation of adequate
systemic therapy.
Conclusion
Solitary amyloidoma of the sacrum is extremely rare. Surgical
treatment is recommended in cases with instability or neu-
rologic symptoms. Complete resection is recommended but
may be associated with signiﬁcant morbidity and functional
impairment. Intralesional resection with adjuvant radiother-
apy can result in a favorable outcome with recovery of
symptoms and local tumor control. However, the overall
prognosis depends on the presence or development of un-
derlying systemic disease that require standard staging pro-
cedures and adequate follow-up and if necessary medical
treatment of multiple myeloma.
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